Gilead is voluntarily recalling 1 lot of Veklury (remdesivir) for Injection 100mg/vial due to the presence of a glass particle found in a vial.

A pair of new studies on COVID-19 antiviral drugs suggest that resistance mutations that emerge after treatment with ...

FDA recalls Gilead's COVID drug Veklury due to glass particles as 21 states show "very high" virus levels in wastewater ...

Gilead Sciences has issued a voluntary recall of one lot of COVID-19 antiviral Veklury, also known as remdesivir, after ...

Gilead Sciences is issuing a voluntary recall of one lot of Veklury (remdesivir) for Injection 100 mg/vial because of glass ...

Foster City, California-based Gilead Sciences, Inc. is recalling one lot of Veklury (remdesivir) for Injection 100 mg/vial for ...

The FDA says that Gilead is reaching out to its distributors and customers by sending UPS Next Day airmail to pharmacies, ...

A small study of 156 people with COVID-19 has found that mutations that confer resistance to antiviral drugs were “commonly detected”, especially in immunocompromised patients. The authors stress that ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury® (remdesivir) for Injection 100 mg/vial, to the consumer level. Gilead received a customer c ...

The manufacturer says the drug is indicated for the treatment of Covid-19 in adults and children, but an unexpected presence ...

The observed lower mortality with remdesivir plus dexamethasone in patients on IMV/ECMO "further supports the growing ...